Dynamic Technology Lab Private LTD Argenx Se Transaction History

Dynamic Technology Lab Private LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $184,675 - $274,215	500 New	500 $246,000
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $198,458 - $233,339	580 New	580 $220,000
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $285,610 - $370,681	-1,050 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $32,450 - $38,563	110 Added 11.7%	1,050 $317,000
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $241,683 - $300,724	940 New	940 $283,000
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $235,121 - $297,308	-1,091 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $139,037 - $253,897	1,091 New	1,091 $246,000
Q1 2020 May 13, 2020	SELL	$108.83 - $165.23 $191,758 - $291,135	-1,762 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $187,811 - $289,338	1,762 New	1,762 $283,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.